NCT02122913 2026-02-05A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat CancerBayerPhase 1 Completed75 enrolled 2 FDA
NCT03056599 2021-09-24Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue SarcomaPresage BiosciencesPhase 1 Completed23 enrolled